To characterize the differential DNA methylation pattern in NSCLC patients, we integrated the DNA methylation data of 78 NSCLC patients before receiving anti-PD-1/PD-L1 therapy. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.